PHASE II-B RANDOMIZED CONTROLLED STUDY OF TISSUE PLASMIN

Project: Research project

Project Details

Description

The specific objectives of this contract are to establish the validity
of current documentation of observed early initial response to treatment
of acute ischemic stroke with recombinant tissue plasminogen activator
(rt-PA) and to establish time limits for delivering such treatment. The
objectives will be accomplished by completing a Phase II-B randomized
controlled clinical study of rt-PA for acute ischemic stroke.
StatusFinished
Effective start/end date6/30/9010/31/95

ASJC

  • Medicine(all)
  • Neuroscience(all)